8:15-8:30 |
Welcome and Introductions |
8:30-9:00 |
Overview of the Bioelectronic Medicine Industry James Cavuoto, Editor, Neurotech Reports
BioElectRx Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including key players, technological roots, and market projections. |
9:00-9:30 |
Keynote Address
Lisa Shafer, Ph.D., Vice President, Product Development, Biogen
A pharmaceutical industry executive and medtech veteran offers their views on the future of bioelectronic medicine. |
9:30-10:15 |
Investment in Bioelectronic Medicine
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Jeff Chu, Managing Partner, Features Capital
Jeffrey Scott Cohen, Director of Research, Ladenburg Thalmann & Co.
In this session, investment professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine. |
10:15-10:45 |
Refreshment Break |
10:45-11:30 |
Entrepreneur Panel I
James Cavuoto, Editor, Neurotech Reports, Moderator
Jay Sanguinetti, Ph.D., CEO and President, Sanmai Technologies
Presentations from executives of emerging bioelectronic medicine firms. |
11:30-12:15 |
Regulatory and Reimbursement Issues
James Cavuoto., Editor, Neurotech Reports, Moderator
David McMullen, M.D., Director, Office of Neurological and Physical Medicine Devices, FDA Center for Devices and Radiological Health (invited)
Eileen Mihas, Program Director, Medical Device Innovation Consortium
Nandan Lad, M.D., Ph.D., Vice Chair of Innovation, Duke Neurosurgery
Victor Pikov, Ph.D., Contributing Editor, BioElectRx Business Report
In this session, we'll look at recent developments in regulatory and reimbursement activity for biolelectronic medicine systems. |
12:15-1:15 |
Luncheon
|
1:15-1:30 |
Luncheon Speaker
|
1:30-2:15 |
Respiratory Disorders
Victor Pikov, Ph.D., Contributing Editor, BioElectRx Business Report, Moderator
Lee Swanson, Vice President, Corporate Development & Ventures, Inspire Medical Systems
The neuromodulation market for treating disorders such as obstructive sleep apnea is one of the most promising segments of the bioelectronic emdicine industry. In this session, we'll look at the competitive outlook and opportunities for innovation. |
2:15-3:00 |
Entrepreneur Panel II
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Frederik Ceyssens, Ph.D., Co-founder and CEO, ReVision Implant
Presentations from executives of emerging bioelectronic medicine firms. |
3:00-3:30 |
Refreshment Break |
3:30-4:15 |
Entrepreneur Panel III
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Presentations from executives of emerging bioelectronic medicine firms. |
4:15-5:00 |
Bowel and Bladder Neuromodulation: A Fireside Chat with Ray Cohen
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Ray Cohen, Former CEO, Axonics Inc.
The market for neuromodulation therapies that treat disorders such as OAB changed dramatically with Boston Scientific's recent purchase of Axonics. In this session, former Axonics CEO Ray Cohen sits down with Jeremy Koff to discuss the new landscape. |
5:00-6:30 |
Cocktail Reception
|
|
|